GM Woods

4.7k total citations · 1 hit paper
113 papers, 2.7k citations indexed

About

GM Woods is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Microbiology. According to data from OpenAlex, GM Woods has authored 113 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 42 papers in Immunology and 40 papers in Microbiology. Recurrent topics in GM Woods's work include Veterinary Oncology Research (40 papers), Microbial infections and disease research (38 papers) and Immunotherapy and Immune Responses (31 papers). GM Woods is often cited by papers focused on Veterinary Oncology Research (40 papers), Microbial infections and disease research (38 papers) and Immunotherapy and Immune Responses (31 papers). GM Woods collaborates with scholars based in Australia, United Kingdom and United States. GM Woods's co-authors include Alexandre Kreiss, A. Bruce Lyons, Cesar Tovar, Katherine Belov, Hannah V. Siddle, Ray M. Lowenthal, Adele F. Holloway, Farzaneh Atashrazm, Joanne L. Dickinson and HK Muller and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

GM Woods

110 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential

2015 271 citations Farzaneh Atashrazm, Ray M. Lowenthal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
GM Woods Australia	29	850	771	670	447	411	113	2.7k
Karsten Skjødt Denmark	40	619 0.7×	363 0.5×	2.3k 3.4×	1.3k 2.9×	340 0.8×	104	4.5k
Masaru Murakami Japan	31	285 0.3×	156 0.2×	538 0.8×	1.4k 3.2×	211 0.5×	237	3.7k
Ole Nielsen Canada	33	349 0.4×	82 0.1×	1.1k 1.6×	866 1.9×	738 1.8×	104	3.6k
Charlotte Gaillard Switzerland	36	189 0.2×	135 0.2×	1.9k 2.8×	784 1.8×	564 1.4×	152	5.4k
Massimo Castagnaro Italy	28	733 0.9×	108 0.1×	313 0.5×	487 1.1×	314 0.8×	122	2.4k
Mats W. Johansson United States	40	585 0.7×	343 0.4×	3.3k 4.9×	710 1.6×	96 0.2×	75	5.2k
Kelly L. Brown Canada	34	328 0.4×	1.4k 1.9×	1.6k 2.5×	1.7k 3.8×	266 0.6×	79	4.2k
Vladimir Vincek United States	34	116 0.1×	92 0.1×	1.6k 2.4×	953 2.1×	386 0.9×	132	3.7k
Darryl J. Hill United Kingdom	30	230 0.3×	498 0.6×	273 0.4×	339 0.8×	188 0.5×	76	2.8k
Franz Koch Austria	31	134 0.2×	197 0.3×	5.5k 8.1×	1.4k 3.2×	954 2.3×	61	7.2k

Countries citing papers authored by GM Woods

Since Specialization

Citations

This map shows the geographic impact of GM Woods's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GM Woods with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GM Woods more than expected).

Fields of papers citing papers by GM Woods

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GM Woods. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GM Woods. The network helps show where GM Woods may publish in the future.

Co-authorship network of co-authors of GM Woods

This figure shows the co-authorship network connecting the top 25 collaborators of GM Woods. A scholar is included among the top collaborators of GM Woods based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GM Woods. GM Woods is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Yuanyuan, et al.. (2022). Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours. Open Biology. 12(10). 220208–220208. 5 indexed citations

Wilson, Richard, Ruth J. Pye, Julian Ratcliffe, et al.. (2022). Cathelicidin-3 Associated With Serum Extracellular Vesicles Enables Early Diagnosis of a Transmissible Cancer. Frontiers in Immunology. 13. 858423–858423. 8 indexed citations

Patchett, Amanda L., Jocelyn M. Darby, Jinying Chen, et al.. (2021). NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers. Journal of Cancer Research and Clinical Oncology. 147(7). 1973–1991. 11 indexed citations

Patchett, Amanda L., Andrew S. Flies, A. Bruce Lyons, & GM Woods. (2020). Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii). Cellular and Molecular Life Sciences. 77(13). 2507–2525. 13 indexed citations

Fernández‐Rojo, Manuel A., Evelyne Deplazes, Sandy S. Pineda, et al.. (2018). Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells. Cell Death Discovery. 4(1). 19–19. 14 indexed citations

Tovar, Cesar, Ruth J. Pye, Alexandre Kreiss, et al.. (2017). Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils. Scientific Reports. 7(1). 43827–43827. 44 indexed citations

Flies, Andrew S., Nicholas B. Blackburn, A. Bruce Lyons, John D. Hayball, & GM Woods. (2017). Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease. Frontiers in Immunology. 8. 513–513. 14 indexed citations

Atashrazm, Farzaneh, Ray M. Lowenthal, GM Woods, et al.. (2015). Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo. Journal of Cellular Physiology. 231(3). 688–697. 43 indexed citations

Patchett, Amanda L., R Latham, Kate H. Brettingham‐Moore, et al.. (2015). Toll-like receptor signaling is functional in immune cells of the endangered Tasmanian devil. Developmental & Comparative Immunology. 53(1). 123–133. 16 indexed citations

10.

Bettiol, SS, et al.. (2014). Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells. Frontiers in Immunology. 5. 251–251. 14 indexed citations

11.

Murchison, Elizabeth P., Cesar Tovar, Arthur Hsu, et al.. (2009). The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer. Science. 327(5961). 84–87. 4 indexed citations

12.

Kreiss, Alexandre, et al.. (2009). The humoral immune response of the Tasmanian devil (Sarcophilus harrisii) against horse red blood cells. Veterinary Immunology and Immunopathology. 130(1-2). 135–137. 20 indexed citations

13.

Lord, Roger, et al.. (2007). Proteomics identifies enhanced expression of stefin A in neonatal murine skin compared with adults: functional implications. British Journal of Dermatology. 156(6). 1156–1162. 19 indexed citations

14.

Woods, GM, et al.. (2003). Antibody response to sheep red blood cells in platypus and echidna. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 136(4). 957–963. 8 indexed citations

15.

Trambas, Christina, Zemin Wang, Maurizio Cianfriglia, & GM Woods. (2001). Evidence that natural killer cells express mini P‐glycoproteins but not classic 170 kDa P‐glycoprotein. British Journal of Haematology. 114(1). 177–184. 30 indexed citations

16.

Woods, GM, et al.. (2001). Prevention of Autoimmunity by Induction of Cutaneous Tolerance. Cellular Immunology. 207(1). 1–5. 7 indexed citations

17.

Woods, GM, et al.. (1996). Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion. Immunology. 88(1). 134–139. 38 indexed citations

18.

Woods, GM, et al.. (1995). Assessment of the available techniques for analysis of P-glycoprotein mediated multidrug resistance. eCite Digital Repository (University of Tasmania). 16. 143–146. 1 indexed citations

19.

Woods, GM, et al.. (1995). Functional asplenia in hemoglobin SC disease. Blood. 85(8). 2238–2244. 56 indexed citations

20.

Woods, GM, et al.. (1989). Evidence for an involvement of T4+ cytotoxic T cells in tumor immunity. Cellular Immunology. 118(1). 126–135. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact